Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (ranolazine in atrial fibrillation following an electrical cardioversion) study
Articolo
Data di Pubblicazione:
2015
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Antiarrhythmic drug; Atrial fibrillation; Atrial flutter; Cardioversion; Electrophysiology; Randomized controlled trial; Ranolazine; Aged; Cardiovascular Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Electrocardiography, Ambulatory; Female; Humans; Male; Middle Aged; Secondary Prevention; Treatment Outcome; Atrial Fibrillation; Electric Countershock; Ranolazine; Cardiology and Cardiovascular Medicine; Physiology (medical)
Elenco autori:
DE FERRARI, Gaetano; Maier, Ls; Mont, L; Schwartz, Peter; Simonis, G; Leschke, M; Gronda, E; Boriani, G; Darius, H; Guillamón Torán, L; Savelieva, I; Dusi, Veronica; Marchionni, N; Quintana Rendón, M; Schumacher, K; Tonini, G; Melani, L; Giannelli, S; Alberto Maggi, C; Camm, J. A.
Link alla scheda completa:
Pubblicato in: